866-997-4948(US-Canada Toll Free)

Erythropoietin Drugs Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Dec 2017

Category :

Pharmaceutical

No. of Pages : 237 Pages

Global Erythropoietin Drugs Market: Snapshot

Erythropoietin is a hormone which produce inside the body from kidney. EPO helps in the development of RBC inside the body and high number of RBC increases the level of hemoglobin in the blood which transport the oxygen in every part of the body. The market for these erythropoietin drugs is anticipated to grow significantly in the forecast period, owing to the rising prevalence of chronic diseases, focus of government and non-government organizations on creating awareness, research and development grants, and fee waivers and tax credits offered, among others.  

Global Erythropoietin Drugs Market: Research Methodologies

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of drugs employed in the treatment of chronic diseases in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for drug class, drug type, drug application, distribution channel, and geography for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each drug class, drug type, drug application, and distribution channel was calculated by considering the prevalence of chronic diseases, erythropoietin drug approvals, regulatory procedures, and the awareness of chronic diseases across all the geographies.

Global Erythropoietin Drugs Market: Segmentation

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on drug class, drug type, drug application, distribution channel, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the erythropoietin drugs market in the current and future scenario. The report also provides Porter’s five forces analysis, the acquisitions timeline of erythropoietin drug companies, SWOT analysis of the market, regulatory scenario, comparative analysis of erythropoietin drug policies, chronic diseases prevalence, pricing scenario of the erythropoietin drugs, major selling erythropoietin drugs, and drug exclusivity of certain of the erythropoietin drugs,  for the market.

Global Erythropoietin Drugs Market: Competitive Landscape

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the erythropoietin drugs market.

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the erythropoietin drugs market report are Amgen Inc., Novartis AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Johnson & Johnson, Wockhardt Ltd., Pfizer, Inc., Biocon Ltd., and Teva Pharmaceutical Industries Ltd. among others.

The Erythropoietin Drugs Market has been segmented as follows:

  • Erythropoietin Drugs Market, by Drug Class, Revenue (US$ Mn) 2015-2025
    • Epoetin Alfa
    • Epoetin Beta
    • Darbepoetin Alfa
    • Others
       
  • Erythropoietin Drugs Market, by Drug Type, Revenue (US$ Mn) 2015-2025
    • Biologics
    • Biosimilar
       
  • Erythropoietin Drugs Market, by Drug Application, Revenue (US$ Mn) 2015-2025
    • Cancer
    • Renal Disease
    • Hematology
    • Neurology
    • Others (Surgery, Wound healing, etc.)
       
  • Erythropoietin Drugs Market, by Drug Application, Revenue (US$ Mn) 2015-2025
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
       
  • Erythropoietin Drugs Market Revenue, by Geography (US$ Mn), 2015-2025
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • Spain
      • France
      • Italy
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of LATAM
    • Middle East and Africa
      • GCC Countries
      • Israel
      • South Africa
      • Rest of MEA

Table of Content

Section 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights 

Section 2 Assumptions and Research Methodology

Section 3 Executive Summary

Section 4 Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.2. Overview
4.3. Market Dynamics 
4.3.1. Drivers
 4.3.1.1. Increase number of patients suffering from anemic condition
 4.3.1.2. Increasing number of patients suffering from cancer
 4.3.1.3. Increasing number of patients suffering from chronic kidney disease
 4.3.1.4. Patent Expirations of Leading Erythropoietin Drugs
 4.3.1.5. Rising demand for improved and advanced erythropoietin drugs products
 4.3.1.6. Reimbursement policies for patients 
4.3.2. Restraints
 4.3.2.1. Highly priced erythropoietin drugs resulting in minimal adoption
 4.3.2.2. High side effects of erythropoietin drugs
4.3.3 Opportunities
4.4. Global Erythropoietin Drugs Market Forecast
4.5. Porter's Five Forces Analysis
4.6. Market Outlook
4.7. Challenges
4.7.1. Cancer Worldwide
4.7.2. Anaemia Worldwide
4.7.3. Chronic Kidney Disease Worldwide
4.7.4. Erythropoietin Pipeline Drugs
4.7.5. Global Price of Erythropoietin Products
4.7.6. Global Regulatory Status 
4.8. Heat Map Analysis 
4.9. Product Profiling for Leading Drugs
4.10. Epoetin alfa
4.11. Epoetin beta
4.12. Darbepoetin alfa
4.13. Others

Section 5 Global Erythropoietin Drugs Market Analysis, by Drug Class
5.1. Key Findings / Developments
5.2. Introduction & Definition 
5.3. Global Erythropoietin Drugs Market Value Share Analysis, by Drug Class
5.4. Global Erythropoietin Drugs Market Forecast, by Drug Class
5.5. Global Erythropoietin Drugs Market Analysis, by Drug Class 
5.5.1. Epoetin Alfa
5.5.2. Epoetin Beta        
5.5.3. Darbepoetin Alfa
5.5.4. Others
5.6. Global Erythropoietin Drugs Market Attractiveness, by Drug Class

Section 6 Global Erythropoietin Drugs Market Analysis, by Drug Type
6.1. Key Findings / Developments
6.2. Introduction & Definition 
6.3. Global Erythropoietin Drugs Market Value Share Analysis, by Drug Type
6.4. Global Erythropoietin Drugs Market Forecast, by Drug Type
6.5. Global Erythropoietin Drugs Market Analysis, by Drug Type
6.5.1. Biologics
6.5.2. Biosimilar
6.6. Global Erythropoietin Drugs Market Attractiveness, by Drug Type

Section 7 Global Erythropoietin Drugs Market Analysis, by Drug Type
7.1. Key Findings / Developments
7.2. Introduction & Definition 
7.3. Global Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
7.4. Global Erythropoietin Drugs Market Forecast, by Distribution Channel 
7.5. Global Erythropoietin Drugs Market Forecast, by Distribution Channel 
7.5.1. Hospital Pharmacy
7.5.2. Retail Pharmacy
7.5.3. Online Pharmacy
7.6. Global Erythropoietin Drugs Market Attractiveness, by Distribution Channel

Section 8 Global Erythropoietin Drugs Market Analysis, by Drug Application
8.1. Key Findings / Developments
8.2. Introduction & Definition 
8.3. Global Erythropoietin Drugs Market Value Share Analysis, by Drug Application
8.4. Global Erythropoietin Drugs Market Forecast, by Drug Application 
8.5. Global Erythropoietin Drugs Market Analysis, by Drug Application
8.5.1. Cancer
8.5.2. Renal Disease
8.5.3. Hematology
8.5.3. Neurology
8.5.4. Others
8.6. Global Erythropoietin Drugs Market Attractiveness, by Drug Application

Section 9 Global Erythropoietin Drugs Market Analysis, by Region
9.1. Global Erythropoietin Drugs Market
9.2. Introduction 
9.3. Global Erythropoietin Drugs Market Value Share Analysis, by Region
9.4. Global Erythropoietin Drugs Market Forecast, by Region
9.5. Global Erythropoietin Drugs Market Attractiveness, by Region

Section 10 North America Erythropoietin Drugs Market Analysis
10.1. Key Findings / Developments
10.2. North America Erythropoietin Drugs Market Overview
10.3. North America Erythropoietin Drugs Market Value Share Analysis, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Erythropoietin Drugs Market Forecast, by Country
10.5. North America Erythropoietin Drugs Market Value Share Analysis, by Drug Class
10.5.1. Epoetin Alfa
10.5.2. Epoetin Beta
10.5.3. Darbepoetin Alfa
10.5.4. Others
10.6. North America Erythropoietin Drugs Market Forecast, by Drug Class
10.7. North America Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
10.7.1. Hospital Pharmacy
10.7.2. Retail Pharmacy
10.7.3. Online Pharmacy
10.8. North America Erythropoietin Drugs Market Forecast, by Distribution Channel
10.9. North America Erythropoietin Drugs Market Value Share Analysis, by Drug Type
10.9.1. Biologics
10.9.2. Biosimilar
10.10. North America Erythropoietin Drugs Market Forecast, by Drug Type
10.11. North America Erythropoietin Drugs Market Value Share Analysis, by Drug Application
10.11.1. Cancer
10.11.2. Renal Disease        
10.11.3. Hematology
10.11.4. Neurology
10.11.5. Others (Surgery, Wound healing, etc.)
10.12. North America Erythropoietin Drugs Market Forecast, by Drug Application
10.13. North America Erythropoietin Drugs Market Attractiveness Analysis

Section 11 Europe Erythropoietin Drugs Market Analysis
11.1 Key Findings / Developments
11.2. Europe Erythropoietin Drugs Market Overview
11.3. Europe Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region
11.3.1. Germany
11.3.2. U.K.
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Erythropoietin Drugs Market Forecast, by Country
11.5. Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Class
11.5.1. Epoetin Alfa
11.5.2. Epoetin Beta
11.5.3. Darbepoetin Alfa
11.5.4. Others
11.6. Europe Erythropoietin Drugs Market Forecast, by Drug Class
11.7. Europe Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
11.7.1. Hospital Pharmacy
11.7.2. Retail Pharmacy
11.7.3. Online Pharmacy
11.8. Europe Erythropoietin Drugs Market Forecast, by Distribution Channel
11.9. Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Type
11.9.1. Biologics
11.9.2. Biosimilar
11.10. Europe Erythropoietin Drugs Market Forecast, by Drug Type
11.11. Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Application
11.11.1. Cancer        
11.11.2. Renal Disease
11.11.3. Hematology
11.11.4. Neurology
11.11.5. Others (Surgery, Wound healing, etc.)
11.12. Europe Erythropoietin Drugs Market Forecast, by Drug Application
11.13. Europe Erythropoietin Drugs Market Attractiveness Analysis

Section 12 Asia Pacific Erythropoietin Drugs Market Analysis
12.1 Key Findings / Developments
12.2. Asia Pacific Erythropoietin Drugs Market Overview
12.3. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region
12.3.1. Japan
12.3.2. China
12.3.3. India
12.3.4. Australia & New Zealand
12.3.5. Rest of APAC
12.4. Asia Pacific Erythropoietin Drugs Market Forecast, by Country
12.5. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Class
12.5.1. Epoetin Alfa
12.5.2. Epoetin Beta
12.5.3. Darbepoetin Alfa
12.5.4. Others
12.6. Asia Pacific Erythropoietin Drugs Market Forecast, by Drug Class
12.7. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
12.7.1. Hospital Pharmacy
12.7.2. Retail Pharmacy
12.7.3. Online Pharmacy
12.8. Asia Pacific Erythropoietin Drugs Market Forecast, by Distribution Channel
12.9. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Type
12.9.1. Biologics
12.9.2. Biosimilar
12.10. Asia Pacific Erythropoietin Drugs Market Forecast, by Drug Type
12.11. Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Application
12.11.1. Cancer
12.11.2. Renal Disease
12.11.3. Hematology
12.11.4. Neurology
12.11.5. Others (Surgery, Wound healing, etc.)
12.12. Asia Pacific Erythropoietin Drugs Market Forecast, by Drug Application
12.13. Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis

Section 13 Asia Pacific Erythropoietin Drugs Market Analysis
13.1 Key Findings / Developments
13.2. Latin America Erythropoietin Drugs Market Overview
13.3. Latin America Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of LA
13.4. Latin America Erythropoietin Drugs Market Forecast, by Country
13.5. Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Class
13.5.1. Epoetin Alfa
13.5.2. Epoetin Beta
13.5.3. Darbepoetin Alfa
13.5.4. Others
13.6. Latin America Erythropoietin Drugs Market Forecast, by Drug Class
13.7. Latin America Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
13.7.1. Hospital Pharmacy
13.7.2. Retail Pharmacy
13.7.3 Online Pharmacy
13.8. Latin America Erythropoietin Drugs Market Forecast, by Distribution Channel
13.9. Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Type
13.9.1. Biologics
13.9.2. Biosimilar
13.10. Latin America Erythropoietin Drugs Market Forecast, by Drug Type
13.11. Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Application
13.11.1. Cancer
13.11.2. Renal Disease
13.11.3. Hematology
13.11.4. Neurology
13.11.5. Others (Surgery, Wound healing, etc.)
13.12. Latin America Erythropoietin Drugs Market Forecast, by Drug Application
13.13. Latin America Erythropoietin Drugs Market Attractiveness Analysis

Section 14 Middle East & Africa Erythropoietin Drugs Market Analysis
14.1. Key Findings / Developments
14.2. Middle East & Africa Erythropoietin Drugs Market Overview
14.3. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region
14.3.1. GCC Countries
14.3.2. South Africa
14.3.3. Israel
14.3.4. Rest of MEA
14.4. Middle East & Africa Erythropoietin Drugs Market Forecast, by Country
14.5. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Class
14.5.1. Epoetin Alfa
14.5.2. Epoetin Beta
14.5.3. Darbepoetin Alfa
14.5.4. Others
14.6. Middle East & Africa Erythropoietin Drugs Market Forecast, by Drug Class
14.7. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel
14.7.1. Hospital Pharmacy
14.7.2. Retail Pharmacy
14.7.3 Online Pharmacy
14.8. Middle East & Africa Erythropoietin Drugs Market Forecast, by Distribution Channel
14.9. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Type
14.9.1. Biologics
14.9.2. Biosimilar
14.10. Middle East & Africa Erythropoietin Drugs Market Forecast, by Drug Type
14.11. Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Application
14.11.1. Cancer
14.11.2. Renal Disease
14.11.3. Hematology
14.11.4. Neurology
14.11.5. Others (Surgery, Wound healing, etc.)
14.12. Middle East & Africa Erythropoietin Drugs Market Forecast, by Drug Application
14.13. Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis

List of Table

Table 01: Most common type of cancer with number of deaths in 2015
Table 02: Ranking of anemia prevalence worldwide
Table 03: Ranking of annual mortality rate by chronic kidney disease in 2013 
Table 04: Erythropoietin Pipeline Drugs
Table 05: Erythropoietin Stimulating Agents Price 2015-2016
Table 06: Regulatory Status 2015-2016
Table 07: Global Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 08: Global Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 09: Global Erythropoietin Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 10: Global Erythropoietin Drugs Market Value (US$ Mn) Forecast, by Drug Application, 2015–2025
Table 11: Global Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 12: North America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 13: North America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 14: North America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 15: North America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 16: North America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Application, 2015–2025
Table 17: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 18: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 19: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 20: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 21: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Application, 2015–2025
Table 22: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 23: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 24: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 25: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 26: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Application, 2015–2025
Table 27: Latin America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 28: Latin America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 29: Latin America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 30: Latin America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 31: Latin America Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Application, 2015–2025
Table 32: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 33: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 34: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 35: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Type, 2015–2025
Table 36: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) Forecast, by Drug Application, 2015–2025

List of Chart

Figure 01: Global Erythropoietin Drugs Market Size (US$ Mn) and Distribution, by Geography, 2016 and 2025
Figure 02: Global Erythropoietin Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 03: Global Erythropoietin Drugs Market Value Share, by Drug Class (2016)
Figure 04: Global Erythropoietin Drugs Market Value Share, by Distribution Channel (2016)
Figure 05: Global Erythropoietin Drugs Market Value Share, by Region (2016)
Figure 06: World cancer prevalence
Figure 07: World anemia prevalence (Preschool age children)
Figure 08: World chronic kidney disease prevalence 
Figure 09: Global Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 10: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Epoetin Alfa, 2015–2025
Figure 11: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Epoetin Beta, 2015–2025
Figure 12: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Darbepoetin Alfa, 2015–2025
Figure 13: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 14: Global Erythropoietin Drugs Market Attractiveness, by Drug Class, 2017–2025
Figure 15: Global Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 16: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biologics, 2015–2025
Figure 17: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biosimilar, 2015–2025
Figure 18: Global Erythropoietin Drugs Market Attractiveness, by Drug Class, 2017–2025
Figure 19: Global Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 20: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacy, 2015–2025
Figure 21: Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacy, 2015–2025
Figure 22: Europe Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician’s Office Laboratories, 2015–2025
Figure 23: Global Erythropoietin Drugs Market Attractiveness, by Distribution Channel, 2017-2025
Figure 24: Global Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 25: Global Erythropoietin Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Cancer, 2015–2025
Figure 26: Global Erythropoietin Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Renal Disease, 2015–2025
Figure 27: Global Erythropoietin Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Hematology, 2015–2025
Figure 28: Global Erythropoietin Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Neurology, 2015–2025
Figure 29: Europe Global Erythropoietin Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 30: Global Erythropoietin Drugs Market Attractiveness, by Drug Application, 2017-2025
Figure 31: Global Erythropoietin Drugs Market Revenue (US$ Mn) Forecast, 2015–2025
Figure 32: Global Erythropoietin Drugs Market Value Share Analysis, by Region, 2016 and 2025
Figure 33: Global Erythropoietin Drugs Market Attractiveness, by Region, 2017-2025
Figure 34: North America Erythropoietin Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 35: North America Erythropoietin Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 36: North America Erythropoietin Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 38: North America Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 39: North America Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 40: North America Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 41: North America Erythropoietin Drugs Market Attractiveness Analysis, by Drug Type, 2017–2025
Figure 42: North America Erythropoietin Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 43: North America Erythropoietin Drugs Market Attractiveness Analysis, by Drug Application, 2017–2025
Figure 44: Europe Erythropoietin Drugs Market Size (US$ Mn) Forecast, 2015–2025
Figure 45: Europe Erythropoietin Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 46: Europe Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 47: Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 48: Europe Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 49: Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 50: Europe Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 51: Europe Erythropoietin Drugs Market Attractiveness Analysis, by Drug Type, 2017–2025
Figure 52: Europe Erythropoietin Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 53: Europe Erythropoietin Drugs Market Attractiveness Analysis, by Drug Application, 2017–2025
Figure 54: Asia Pacific Erythropoietin Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 55: Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 56: Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 57: Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 58: Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 59: Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 60: Asia Pacific Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 61: Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis, by Drug Type, 2017–2025
Figure 62: Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 63: Asia Pacific Erythropoietin Drugs Market Attractiveness Analysis, by Drug Application, 2017–2025
Figure 64: Latin America Erythropoietin Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 65: Latin America Erythropoietin Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 66: Latin America Erythropoietin Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 67: Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 68: Latin America Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 69: Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 70: Latin America Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 71: Latin America Erythropoietin Drugs Market Attractiveness Analysis, by Drug Type, 2017–2025
Figure 72: Latin America Erythropoietin Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 73: Latin America Erythropoietin Drugs Market Attractiveness Analysis, by Drug Application, 2017–2025
Figure 74: Middle East & Africa Erythropoietin Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 75: Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis, by Country/Sub-region, 2017–2025
Figure 76: Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 77: Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 78: Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 79: Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Type, 2016 and 2025
Figure 80: Middle East & Africa Erythropoietin Drugs Market Value Share Analysis, by Drug Application, 2016 and 2025
Figure 81: Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis, by Drug Type, 2017–2025
Figure 82: Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 83: Middle East & Africa Erythropoietin Drugs Market Attractiveness Analysis, by Drug Application, 2017–2025

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *